Back
Insurance

Understanding Pharmac – The Definitive Guide

Our guide explains how New Zealand’s medicine-buying agency works, what it means for your health, and why private health insurance helps fill the gaps.

Pharmac Explained & Annual Review NZ
Updated 9 March 2026
Important: This guide is factual and neutral – all data comes from Pharmac’s latest annual report.


Key Findings

  • Medicines Budget: $1.69B – Pharmac’s fixed annual budget for all publicly funded medicines, vaccines, and medical devices.

  • Total gross spending: $2.71B – Pharmac stretches its budget through commercial rebates, effectively doubling its buying power.

  • 4.182 million New Zealanders received funded medicines in 2024/25 – essentially the entire population.

  • 66 new medicines funded following a $604M budget increase – 33 for cancer, 33 for other conditions (~248,000 people benefited).

  • 89,436 extra patients benefitted from Pharmac decisions implemented in 2024/25.

  • 188,841 medical device line items under national contract, worth $655M.

  • The gap matters: Not every available medicine is funded – one of the main reasons people purchase health insurance.


The Bigger Picture – What You Need to Know

  • Pharmac affects every New Zealander: Every prescription you collect, every hospital treatment, every vaccination – Pharmac’s decisions determine what’s available and what you pay. Yet many people don’t understand how the system works.

  • The fixed budget creates trade-offs: Funding one medicine may mean another cannot be funded. Some medicines available overseas may never be funded in NZ.

  • The gap drives health insurance purchases: Modern cancer immunotherapies can cost $50,000–$100,000+ per year. If Pharmac doesn’t fund them, you pay privately or rely on insurance. Benefits vary between insurers, so understanding the gap is key.

  • The system is changing: Pharmac received its biggest-ever budget uplift in 2024, funded 66 new medicines, and is undergoing a major organisational reset focusing on transparency and consumer engagement.


What This Guide Covers

  • What is Pharmac?

  • The Medicines Budget – Where the Money Goes

  • How Pharmac Decides Which Medicines to Fund

  • Understanding the Pharmaceutical Schedule (NZ’s Medicine Menu) and the NPPA Process

  • Pharmac and Private Health Insurance – Why the Gap Matters

  • How to Navigate the System and Your Rights as a Patient

  • Pharmac 2024–2025 – A Year in Review

  • Frequently Asked Questions


Important Information

This guide is for general information only and does not constitute medical, legal, or financial advice. For information about specific medicines, consult Pharmac’s website or speak with your doctor.
All data referenced is from the Pharmac Annual Report for the year ended 30 June 2025 (published October 2025).


Know This First: How Health Insurance Covers the Pharmac Gap

  • Non-Pharmac cancer drug limits: $10,000–$20,000 depending on the insurer – when treatment can cost $50,000–$150,000, the difference matters.

  • Some insurers do not cover immunotherapy; add-ons vary between providers.

  • LifeDirect allows you to compare real quotes from Southern Cross, AIA, nib, Partners Life, and Unimed side-by-side in under 30 seconds – no cost, no obligation.


What is Pharmac NZ?

Pharmac (the Pharmaceutical Management Agency, Te Pataka Whaioranga) is the Crown entity responsible for deciding which medicines, vaccines, medical devices, and related products are publicly funded.

  • Established: 1993

  • Goal: Maximise health outcomes for New Zealanders from a fixed government budget.

  • How it works: Pharmac negotiates prices with pharmaceutical companies, leveraging bulk buying to reduce costs.

  • Most prescriptions: Maximum co-payment $5 (often free).

  • Every prescription, hospital treatment, and vaccination is influenced by Pharmac decisions.


Understanding Pharmac’s Legal Objective

Section 68 of the Pae Ora (Healthy Futures) Act 2022: Pharmac must deliver the best health outcomes possible within the funding provided. This two-part mandate explains why trade-offs are necessary – one medicine funded may mean another cannot be.


Governance

  • Pharmac is a Crown entity under the Crown Entities Act 2004, accountable to the Associate Minister of Health.

  • The Board, appointed by the Minister, sets strategic direction, approves funding decisions, and oversees performance.

  • Advisory committees: Clinicians, pharmacists, economists, and consumer representatives provide guidance. Key committees include the Pharmacology and Therapeutics Advisory Committee (PTAC) and specialist subcommittees covering cancer, rare disorders, and vaccines.

Fact Detail
Established 1993
Type Crown entity under Crown Entities Act 2004
Legislation Pae Ora (Healthy Futures) Act 2022, s68
Reports to Associate Minister of Health
Board Chair 2024/25 Hon Paula Bennett
Employees 195 (as at 30 June 2025)
Website pharmac.govt.nz

 


The Medicines Budget – Where the Money Goes

Pharmac manages the Medicines Budget, covering community and hospital medicines, vaccines, medical devices, and related products.

Category Examples
Community medicines Antibiotics, statins, inhalers, cancer drugs
Hospital medicines IV antibiotics, anaesthetics, chemotherapy
Vaccines MMR, flu, COVID-19, HPV
Medical devices Hip implants, pacemakers, bandages, syringes
Related products Nicotine replacement, haemophilia treatments

How it works: Pharmac stretches the $1.69B budget to $2.71B in 2024/25 via confidential rebates and commercial agreements.


How Pharmac Decides Which Medicines to Fund

Factors for Consideration: Health need, clinical benefits and risks, cost-effectiveness, budget impact, suitability, health equity.

Assessment Journey:

  1. Submission from pharmaceutical company.

  2. Clinical assessment by Pharmac team and PTAC.

  3. Economic evaluation.

  4. Commercial negotiation.

  5. Public consultation (for significant decisions).

  6. Board decision.

Average time from application to decision: 36 months (recent applications). Urgent cases can be faster; some complex cases average 95 months.


Pharmaceutical Schedule & NPPA

  • Schedule: Official list of all publicly funded medicines and related products, including rules, prices, and restrictions.

  • Special Authority: Some medicines only funded for specific patients.

  • NPPA (Named Patient Pharmaceutical Assessment): Exceptional cases can access non-funded medicines via application by your doctor.

Patient advocacy: Speak with your GP or specialist, or contact relevant patient groups for guidance.


Pharmac and Private Health Insurance – Why the Gap Matters

  • Not all effective treatments are funded in NZ.

  • Health insurance can cover expensive non-Pharmac medicines.

  • Understanding the funding gap makes insurance benefits clearer.

Gap Type What This Means Typical Cost Without Insurance
Pipeline medicines Newly approved, not yet funded 3-year wait average
Declined medicines Cost-effectiveness not met May never be funded
Latest therapies Cutting-edge immunotherapies, biologicals $50k–$150k/year

 


Navigating the System & Your Rights

  • Funded medicine: GP/specialist → pharmacy → pay co-payment ($5 max). Prescription Subsidy Scheme: free after 20 items/year.

  • Non-funded medicine: Discuss alternatives, check insurance, or NPPA eligibility.

  • Advocacy: Patient groups, public consultation, MPs, direct feedback to Pharmac.

Patient rights: Transparency, consultation, NPPA access, complaints, Official Information Act requests, consumer engagement workshops.


Pharmac 2024–2025 – A Year in Review

  • $604M government budget uplift enabled 66 new medicines (33 cancer, 33 other conditions), benefiting ~248,000 people.

  • 83 total decisions: largest programme in Pharmac’s history; normally 20–45 decisions/year.

Key Medicine Highlights:

  • Cancer treatments: Tecentriq + Vegzelma, Opdivo + Yervoy, Keytruda, etc.

  • Diabetes: Funded continuous glucose monitors (~12,000 first-year recipients).

  • ADHD meds: Vyvanse funded; prescribing widened to GPs/nurse practitioners.

  • Other additions: Contraceptives, HRT patches, eczema/arthritis drugs, hospital antibiotics, liquid nutrition.

NPPA Performance: 79% initial applications decided within 10 working days.
Organisational changes: New CEO, board updates, consumer engagement reset, five-year change programme, workforce diversity stats.


Frequently Asked Questions

  • Prescription cost: Max $5 per item; free after 20 items/year; children & card holders free.

  • Non-funded medicines: Pay privately or check insurance/NPPA.

  • New medicine funding: ~36 months for recent applications.

  • Cancer coverage: Expanded, but not all drugs funded. Gap often drives insurance.

  • NZ vs overseas: Single-buyer model recognised internationally; smaller budget limits some drugs.

  • Appeals: No formal process; feedback, OIA, MP contact, NPPA for exceptions.

  • Medsafe vs Pharmac: Medsafe approves safety; Pharmac decides public funding.

  • Pharmaceutical Schedule: List of funded medicines, vaccines, devices.

Health Insurance: Covers non-Pharmac gaps; LifeDirect lets you compare real quotes from Southern Cross, AIA, nib, Partners Life, and Unimed in under 30 seconds – free, no obligation.

Starting a quote takes seconds, get on your way to being prepared for the unexpected.

Get quotes
Disclosure statement Complaints Security & Privacy